Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We're on a mission to answer the unmet needs of people living with CNS diseases by developing safe, potent, and rapid-acting therapies that address hallmark disease biology. Our therapeutic candidates are specifically designed to target underlying synaptic dysfunction to restore healthy and balanced brain signaling. We are developing novel mechanisms that represent a more direct approach to enhancing synaptic function and neur...
We're on a mission to answer the unmet needs of people living with CNS diseases by developing safe, potent, and rapid-acting therapies that address hallmark disease biology. Our therapeutic candidates are specifically designed to target underlying synaptic dysfunction to restore healthy and balanced brain signaling. We are developing novel mechanisms that represent a more direct approach to enhancing synaptic function and neuroplasticity compared to other next-generation rapid antidepressants. By rethinking what’s possible, we’re creating hope for better treatments and better lives.

List your booth number for exhibitions, ask us